In esophageal squamous cell carcinoma, the five-year survival of patients with a high expression of Cx26 is lower than that of patients with no or low expression, and high expression of Cx26 is often accompanied by lymph node metastasis [241]. Here, GJB2 is linked to esophageal squamous cell carcinoma.